A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the … [Read More...] about Study highlights benefits of automated insulin delivery for children in UK
Main Content
Drug Tech
Today on Drug Delivery Business
- Dexcom stock slides despite Q1 beats, sales guidance increase
- BD warns on some neXus V700 infusion pumps outside the U.S.
- FDA says InfuTronix infusion pump recall includes 1 death
- ICU Medical’s Smiths Medical is reportedly closing a New Hampshire plant, cutting 220 jobs
- Study highlights benefits of automated insulin delivery for children in UK
- Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit
- Eli Lilly acquires new injectable medicine manufacturing plant
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
Dexcom stock slides despite Q1 beats, sales guidance increase
By Sean Whooley
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of DXCM dipped about 7% to $128.40 apiece after the market closed today. MassDevice’s MedTech 100 … [Read More...] about Dexcom stock slides despite Q1 beats, sales guidance increase
FDA says InfuTronix infusion pump recall includes 1 death
By Sean Whooley
The FDA today shared new information on an infusion pump recall from InfuTronix that included one report of death. Following a voluntary removal, the FDA deemed the recall Class I, the most serious kind, earlier this month. It affects 52,328 … [Read More...] about FDA says InfuTronix infusion pump recall includes 1 death
ICU Medical’s Smiths Medical is reportedly closing a New Hampshire plant, cutting 220 jobs
By Sean Whooley
ICU Medical's Smiths Medical unit reportedly plans to close a New Hampshire manufacturing facility that houses about 220 employees. The infusion technology maker plans to close the plant in Keene, New Hampshire, next year, according to the Keene … [Read More...] about ICU Medical’s Smiths Medical is reportedly closing a New Hampshire plant, cutting 220 jobs
Study highlights benefits of automated insulin delivery for children in UK
By Sean Whooley
A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the … [Read More...] about Study highlights benefits of automated insulin delivery for children in UK
Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit
By Sean Whooley
William Blair analyst Margaret Kaczor reported surprise at the increase in users of CGM within the non-insulin and basal insulin populations. Kaczor expects Dexcom and Abbott to benefit from the trend with their next-generation CGM offerings after … [Read More...] about Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit
Concept Medical enrolls first patient in drug-coated balloon study
By Sean Whooley
Concept Medical announced today that it commenced the FDA investigational device exemption (IDE) study of its MagicTouch system. MagicTouch, a sirolimus drug-coated balloon (DCB), treats in-stent restenosis (ISR) in coronary artery disease (CAD). … [Read More...] about Concept Medical enrolls first patient in drug-coated balloon study
Kindeva Drug Delivery has a new COO
By Sean Whooley
Kindeva Drug Delivery announced today that it appointed Denis Johnson as its new chief operating officer (COO). Johnson's responsibilities include leading global operations for Kindeva's manufacturing and R&D facilities across the U.S. and UK. … [Read More...] about Kindeva Drug Delivery has a new COO
Fresenius Kabi has a Class I recall of Ivenix Infusion System software
The FDA this week labeled Fresenius Kabi’s recall of some Ivenix Infusion Systems (IIS) as Class I, the most serious kind. Fresenius Kabi USA issued the recall of Ivenix Infusion System LVP software, its infusion pump software, due to an issue of … [Read More...] about Fresenius Kabi has a Class I recall of Ivenix Infusion System software
Ypsomed, ten23 health collab on YpsoDose patch injector
By Sean Whooley
Ypsomed announced today that it entered into a partnership with ten23 health to commercialize its YpsoDose wearable injector. Burgdorf, Switzerland-based Ypsomed designed YpsoDose for the subcutaneous self-injection of large-volume doses. ten23 … [Read More...] about Ypsomed, ten23 health collab on YpsoDose patch injector
Glucotrack expands CGM tech to spinal epidural space
By Sean Whooley
Glucotrack (Nasdaq:GCTK) announced today that it plans to expand its glucose monitoring technology to measure glucose in the epidural space. Rutherford, New Jersey-based Glucotrack said CGM taking readings in the spinal epidural space could … [Read More...] about Glucotrack expands CGM tech to spinal epidural space
In case you missed it
- RenovoRx raises $11.1M to support oncology drug delivery trial
- Cook Medical wins DOD contract for drug-eluting stents
- Dexcom, MD Revolution partner to integrate CGM into remote care platform
- OM1, Medtronic partner on drug-eluting implant study
- Insulet applauds as UK begins artificial pancreas rollout
- Biolinq raises $58M to support intradermal glucose sensor
- InfuTronix has a Class I infusion pump recall
- Tandem Mobi automated insulin pump wins FDA nod for expanded pediatric use
- FDA clears Baxter Novum IQ large-volume infusion pump, Dose IQ safety software
- Tandem Diabetes Care taps miniaturization and automation for its latest systems
- Ypsomed sells pen needle, blood glucose monitor business to focus on insulin pump
- ivWatch wins FDA nod for infusion monitoring tech
- BD ups domestic syringe production in wake of FDA warnings on syringes made in China
- Insulet picks new CFO following McMillan’s move to 3M spinoff
- FDA issues warning letter to Medline over plastic syringes from China
Clinical Trials
Study highlights benefits of automated insulin delivery for children in UK
A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the country with an artificial pancreas. The study aimed to assess the efficacy of […]
Concept Medical enrolls first patient in drug-coated balloon study
Concept Medical announced today that it commenced the FDA investigational device exemption (IDE) study of its MagicTouch system. MagicTouch, a sirolimus drug-coated balloon (DCB), treats in-stent restenosis (ISR) in coronary artery disease (CAD). Dr. Said Ashraf enrolled the first patient in the MAGICAL-ISR study at the AtlantiCare Institute in Atlantic City, New Jersey. The balloon […]
Glucotrack expands CGM tech to spinal epidural space
Glucotrack (Nasdaq:GCTK) announced today that it plans to expand its glucose monitoring technology to measure glucose in the epidural space. Rutherford, New Jersey-based Glucotrack said CGM taking readings in the spinal epidural space could integrate with existing treatments for painful diabetic neuropathy (PDN). Specifically, Glucotrack sees spinal cord stimulation (SCS) technology as a potential integration […]
OM1, Medtronic partner on drug-eluting implant study
OM1 today announced positive results from its partnership with Medtronic (NYSE:MDT) evaluating the Propel corticosteroid-eluting implants. The Propel bioabsorbable implant family came to Medtronic through its acquisition of IntersectENT in 2022. OM1 and Medtronic partnered on their study to focus on healthcare resource use and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent […]
The biggest diabetes tech news out of ATTD 2024
Catch up on the latest in diabetes tech from Dexcom, Abbott, Roche Diabetes Care, Insulet, Medtronic and Know Labs. Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). In this year’s 17th installment, some of the biggest names shared new studies and technologies set to […]